Prelude Therapeutics Incorporated Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ANTX
|
AN2 Therapeutics, Inc. | $1.09 | $60.55 M | -0.81 | 41 | $0 |
 BCEL
|
Atreca, Inc. | $0.09 | $3.66 M | -0.04 | 90 | $770,000 |
 BDTX
|
Black Diamond Therapeutics, Inc. | $3.26 | $291.95 M | -3.13 | 54 | $0 |
 CCCC
|
C4 Therapeutics, Inc. | $6.10 | $320.64 M | -1.97 | 145 | $20.76 M |
 CYT
|
Cyteir Therapeutics, Inc. | $3.02 | $108.71 M | -3.25 | 46 | $0 |
 ELYM
|
Eliem Therapeutics, Inc. | $5.11 | $258.33 M | -17.08 | 9 | $0 |
 FHTX
|
Foghorn Therapeutics Inc. | $8.90 | $332.53 M | -2.73 | 116 | $34.16 M |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $9.36 | $243.38 M | -1.59 | 129 | $0 |
 KYMR
|
Kymera Therapeutics, Inc. | $47.66 | $2.02 B | -13.13 | 184 | $78.59 M |
 MLYS
|
Mineralys Therapeutics, Inc. | $13.49 | $652.38 M | -6.03 | 28 | $0 |
|
MOLN
|
Molecular Partners AG | $5.75 | $135.05 M | -2.03 | 167 | $7.04 M |
 NRIX
|
Nurix Therapeutics, Inc. | $25.45 | $930.10 M | -5.89 | 284 | $76.99 M |
 PASG
|
Passage Bio, Inc. | $0.64 | $73.04 M | -0.77 | 58 | $0 |
 PEPG
|
PepGen Inc. | $6.81 | $537.15 M | -5.11 | 72 | $0 |
 PHVS
|
Pharvaris N.V. | $23.16 | $843.31 M | -5.8 | 83 | $0 |
 RVMD
|
Revolution Medicines, Inc. | $56.75 | $6.66 B | -10.51 | 443 | $11.58 M |
 RZLT
|
Rezolute, Inc. | $5.45 | $229.57 M | -5.02 | 51 | $0 |
|
STTK
|
Shattuck Labs, Inc. | $1.20 | $333.81 M | -3.64 | 75 | $1.66 M |
 TCRR
|
TCR2 Therapeutics Inc. | $1.48 | $58.11 M | -0.35 | 58 | $0 |